Rapid Readouts: The Phase 1/2 ANCHOR Trial for Melphalan Flufenamide in Relapsed/Refractory Multiple Myeloma

Video

Related Videos
Sundar Jagannath, MBBS
Changchun Deng, MD, PhD
Sundar Jagannath, MBBS
Elias Jabbour, MD
Guenther Koehne, MD, PhD
Joseph G. Jurcic, MD
Krina K. Patel, MD, MSc
Ibrahim Aldoss, MD
Sundar Jagannath, MBBS
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University